- India
- /
- Healthcare Services
- /
- NSEI:METROPOLIS
3 Growth Companies With High Insider Ownership On The Indian Exchange
Reviewed by Simply Wall St
Over the last 7 days, the Indian market has dropped 1.0%, but it is up 39% over the last year, with earnings expected to grow by 17% per annum in the coming years. In this context, identifying growth companies with high insider ownership can be crucial as it often indicates strong confidence from those who know the business best.
Top 10 Growth Companies With High Insider Ownership In India
Name | Insider Ownership | Earnings Growth |
Archean Chemical Industries (NSEI:ACI) | 22.9% | 33.7% |
Kirloskar Pneumatic (BSE:505283) | 30.4% | 30.1% |
Dixon Technologies (India) (NSEI:DIXON) | 24.6% | 36.6% |
Happiest Minds Technologies (NSEI:HAPPSTMNDS) | 32.5% | 22.2% |
Jupiter Wagons (NSEI:JWL) | 10.8% | 27.4% |
Paisalo Digital (BSE:532900) | 16.3% | 24.8% |
Apollo Hospitals Enterprise (NSEI:APOLLOHOSP) | 10.4% | 32.3% |
Rajratan Global Wire (BSE:517522) | 19.8% | 35.8% |
Aether Industries (NSEI:AETHER) | 31.1% | 45.9% |
Pricol (NSEI:PRICOLLTD) | 25.5% | 24% |
Here's a peek at a few of the choices from the screener.
Mrs. Bectors Food Specialities (NSEI:BECTORFOOD)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Mrs. Bectors Food Specialities Limited manufactures and distributes various food products in India and has a market cap of ₹106.23 billion.
Operations: Mrs. Bectors Food Specialities Limited generates revenue of ₹16.89 billion from its food products segment.
Insider Ownership: 36.2%
Revenue Growth Forecast: 14.7% p.a.
Mrs. Bectors Food Specialities shows promising growth potential with forecasted annual earnings growth of 19.4%, outpacing the Indian market average of 17%. The company has demonstrated strong recent performance, with a 25.6% increase in earnings over the past year and first-quarter revenue rising to ₹4.44 billion from ₹3.79 billion a year ago. High insider ownership aligns management interests with shareholders, supporting confidence in its strategic direction amidst ongoing fundraising efforts and board changes.
- Unlock comprehensive insights into our analysis of Mrs. Bectors Food Specialities stock in this growth report.
- Insights from our recent valuation report point to the potential overvaluation of Mrs. Bectors Food Specialities shares in the market.
Kalpataru Projects International (NSEI:KPIL)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Kalpataru Projects International Limited offers engineering, procurement, and construction (EPC) services across various sectors including power transmission and distribution, buildings and factories, water, railways, oil and gas, and urban infrastructure both in India and internationally with a market cap of ₹227.08 billion.
Operations: Kalpataru Projects International Limited generates revenue primarily from its Engineering, Procurement and Construction (EPC) segment amounting to ₹194.92 billion, with additional contributions from Development Projects totaling ₹2.81 billion.
Insider Ownership: 13.4%
Revenue Growth Forecast: 13% p.a.
Kalpataru Projects International demonstrates growth potential with forecasted annual earnings growth of 29%, outpacing the Indian market average of 17%. Despite recent regulatory challenges, including multiple GST-related fines and penalties aggregating millions of INR, the company maintains a strong financial position. High insider ownership aligns management interests with shareholders, supporting confidence in its strategic direction. Recent first-quarter revenue rose to ₹46.09 billion from ₹42.59 billion a year ago, reflecting operational resilience amidst ongoing compliance issues.
- Click here and access our complete growth analysis report to understand the dynamics of Kalpataru Projects International.
- Our valuation report here indicates Kalpataru Projects International may be undervalued.
Metropolis Healthcare (NSEI:METROPOLIS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Metropolis Healthcare Limited offers diagnostic services in India and internationally, with a market cap of ₹109.62 billion.
Operations: Metropolis Healthcare Limited generates revenue primarily from its pathology services, amounting to ₹12.44 billion.
Insider Ownership: 18.8%
Revenue Growth Forecast: 11.2% p.a.
Metropolis Healthcare, with significant insider ownership, is poised for growth with forecasted annual earnings expansion of 23.33%, surpassing the Indian market average of 17%. Recent executive changes, including appointing a new Chief Information Officer and reassigning board roles, aim to strengthen leadership. The company reported first-quarter revenue of ₹3.16 billion and net income of ₹379.47 million, reflecting solid performance despite substantial insider selling over the past quarter.
- Click to explore a detailed breakdown of our findings in Metropolis Healthcare's earnings growth report.
- Our valuation report here indicates Metropolis Healthcare may be overvalued.
Next Steps
- Click through to start exploring the rest of the 90 Fast Growing Indian Companies With High Insider Ownership now.
- Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
- Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.
Looking For Alternative Opportunities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NSEI:METROPOLIS
Metropolis Healthcare
Provides diagnostic services in India and internationally.
Flawless balance sheet with reasonable growth potential.